4'-[[1,4'-Dimethyl-2'-propyl(2,6'-bi-1H-benzimidazol)-1'-yl]-methyl]-1,1'-biphenyl-2-carboxylicacid 1,1-dimethylethylester

CAS: 144702-26-1

Ref. 3D-FD148340

Información del producto

• Nombre: 4'-[[1,4'-Dimethyl-2'-propyl(2,6'-bi-1H-benzimidazol)-1'-yl]-methyl]-1,1'-biphenyl-2-carboxylicacid 1,1-dimethylethylester

Descripción

4'-[[1,4'-Dimethyl-2'-propyl(2,6'-bi-1H-benzimidazol)-1'-yl]-methyl]-1,1'-biphenyl-2-carboxylic acid 1,1-dimethylethyl ester (DMBPC) is a drug substance that is used in the manufacture of solid oral dosage forms. It has been shown to be present at low levels as an impurity in other drug substances. The presence of this impurity has been shown to cause problems with the chromatographic and hplc methods used for its quantification. The following are some important aspects of DMBPC: A. Impurities: The purity of DMBPC is 98%. The impurity profile includes 6% 2-propylbenzimidazole (2PB), 3% 4'-[[2-(6' -methoxycarbony

• Marca: Biosynth

Propiedades químicas

• Peso molecular: 570.72 g/mol
• Fórmula: C₃₇H₃₈N₄O₂
• Pureza: Min. 95%
• InChI: InChI=1S/C37H38N4O2/c1-7-12-33-39-34-24(2)21-27(35-38-30-15-10-11-16-31(30)40(35)6)22-32(34)41(33)23-25-17-19-26(20-18-25)28-13-8-9-14-29(28)36(42)43-37(3,4)5/h8-11,13-22H,7,12,23H2,1-6H3
• Clave InChI: InChIKey=JSCFLEBEWCTASN-UHFFFAOYSA-N
• SMILES: CCCc1nc2c(C)cc(-c3nc4ccccc4n3C)cc2n1Cc1ccc(-c2ccccc2C(=O)OC(C)(C)C)cc1